Skip to main content
Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0086
-0.0001 (-1.15%)
Apr 29, 2026, 3:57 PM EST

Evofem Biosciences Revenue

In the year 2025, Evofem Biosciences had annual revenue of $20.18M with 4.23% growth. Evofem Biosciences had revenue of $9.56M in the quarter ending December 31, 2025, with 34.59% growth.

Revenue
20.18M
Revenue Growth
+4.23%
P/S Ratio
0.06
Revenue / Employee
695.97K
Employees
29
Market Cap
1.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202520.18M820.00K4.23%
Dec 31, 202419.36M1.15M6.28%
Dec 31, 202318.22M1.38M8.20%
Dec 31, 202216.84M8.59M104.23%
Dec 31, 20218.24M7.80M1,748.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
LakeShore Biopharma 84.75M
GB Sciences 97.24K
Eastgate Biotech 137.64K
Lyra Therapeutics 398.00K
International Stem Cell 9.10M
Adaptimmune Therapeutics 65.09M
Enzolytics 46.59K
Revenue Rankings

Evofem Biosciences News

More News